Consumer Research
Organigram Pulls Sanity Group Into a Single Global Structure
TORONTO – Organigram Global Inc. did not wait out the ...
Yale Budget Lab Outlines Multibillion Dollar Future for Federal Cannabis
NEW HAVEN – The fiscal argument for federal Cannabis legalization ...
Definium Delivers Positive Phase 3 Data for LSD Candidate in GAD
NEW YORK – Definium Therapeutics Inc. has released topline results ...
Trulieve Completes Redomicile to Delaware
TALLAHASSEE – Trulieve Cannabis Corp. completed its redomiciliation from British Columbia, Canada, to the State of Delaware, following a shareholder vote and a Final Order from the British Columbia Supreme Court. The redomicile took effect ...
PSYCH Symposium Rebrands as Mind Forward for Another London Event
LONDON – The organizers of Europe’s established psychedelic medicine conference have rebranded the platform and expanded its focus. The new identity, Mind Forward, will host a one-day symposium in London later this year. PSYCH has ...
Organigram Reports Q3 Fiscal 2026 Financial Results
TORONTO – Organigram Global Inc. released its third-quarter fiscal 2026 results, showing the first full contribution from its recent European acquisition alongside continued strength in the Canadian market. The company reported higher sales and adjusted ...
High Tide Closes BMO Credit Facility, Issues Q3 Guidance
CALGARY – High Tide Inc. closed its C$40 million senior secured credit facilities with Bank of Montreal (BMO), replacing an existing arrangement with ConnectFirst Credit Union and substantially lowering the company's cost of capital. The ...
LEEF Brands Reports Q2 2026 Financial Results
VANCOUVER – LEEF Brands Inc. posted gross profit up 62% and gross margin that nearly doubled year-over-year, even as top-line revenue fell by 16%. Net revenue reached $7.3 million, down from $8.7 million in Q2 ...
ACT LAB Enters NJ Cannabis Market with Sriven Labs Acquisition
TRENTON – ACT LAB, a Cannabis and hemp testing and compliance laboratory network, announced its entry into New Jersey through the acquisition of Sriven Labs (SV Labs – NJ), a licensed and ISO-accredited testing laboratory ...
Cresco Labs Reports Q2 2026 Financial Results
CHICAGO – Cresco Labs Inc. released its second-quarter 2026 financial results, offering a clear look at how the multistate operator performed through the end of June. The company, known for its branded products and Sunnyside ...
Vireo Growth Closes Colorado Retail Deal, Secures Bank-Led Credit Line
MINNEAPOLIS – Vireo Growth Inc. announced it had received all required regulatory approvals and formally closed its acquisition of certain Colorado retail assets from PharmaCann Inc. Additionally, the company disclosed a senior secured asset-based revolving ...
Trulieve Reports Q2 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. released its second-quarter 2026 financial results, reflecting a period that included the deconsolidation of Harvest operations, recognition from TIME magazine, and the company's listing on the New York Stock Exchange. ...
NY Cannabis Market Gains New Outdoor Sales Path
NEW YORK – New York Governor Kathy Hochul signed legislation that expands the ways licensed microbusinesses and dispensaries can sell Cannabis products at approved community events. The measure aims to give smaller operators more direct ...
Cannara Biotech Wraps Up Medican Organic Acquisition
MONTREAL – Cannara Biotech Inc. announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. for an aggregate purchase price of $2.8 million. On the surface, that's a modest ...
Aprio Targets Cannabis Sector in Price Kong Acquisition
ATLANTA-PHOENIX – Aprio, the 20th largest business advisory and accounting firm in the United States, announced it had entered into an agreement to acquire Price Kong, a Phoenix-based CPA and advisory firm. The transaction, effective ...
RYTHM Reports Q1 2026 Financial Results
ROLLING MEADOWS – RHYTHM Inc. disclosed stronger results for the first quarter of 2026 as the company continued its shift toward branded hemp-derived THC products and licensing deals. Revenue from continuing operations came in at ...
High Tide Scores Big in Germany Through Remexian Distribution
CALGARY-BERLIN – High Tide Inc. reported that its majority-owned German subsidiary, Remexian Pharma GmbH, distributed 7.6 tons of medical Cannabis flower into the German market during the second fiscal quarter ended April 30, 2026 – ...
Curaleaf Reports Q1 2026 Financial Results
STAMFORD – Curaleaf Holdings Inc. posted its strongest revenue growth in years during the first quarter of 2026, swinging to a net profit just as the federal regulatory environment under which the industry operates began ...
LeafLink Releases 2026 Wholesale Cannabis Pricing Guide
NEW YORK – LeafLink, a unified B2B marketplace and technology platform built specifically for the Cannabis industry, published its annual 2026 Wholesale Cannabis Pricing Guide, delivering one of the most comprehensive data snapshots the legal ...
Psilocybin Shows Promise for Those Ready to Break Free from Nicotine
BALTIMORE – Researchers at Johns Hopkins University have published findings from a pilot randomized clinical trial that points to potential advantages of psilocybin-assisted therapy over standard nicotine replacement for helping adults quit cigarettes. Published in ...
Hall of Flowers Relocates Northern California Event to Sacramento
LOS ANGELES – After eight years in Santa Rosa, the B2B Cannabis trade show Hall of Flowers is moving its Northern California event to the Cal Expo exhibition halls in Sacramento. The newly confirmed dates, ...
Vireo to Acquire FLUENT in All-Stock Deal
LOS ANGELES – Vireo Growth Inc. announced it has signed a definitive agreement to absorb FLUENT Corp. in an all-stock transaction, a deal that, if approved, would make Vireo the third-largest operator in medical-only Florida's ...
DEA Assigns Specific Schedule I Listing and Drug Code to HHC
WASHINGTON – The Drug Enforcement Administration (DEA) has issued a final rule that formally lists hexahydrocannabinol (HHC) as a Schedule I controlled substance with its own dedicated drug code. The notice, published in the Federal ...
Allied Market Research: Global Cannabis Market to Generate $149B by 2031
PORTLAND – A report recently published by Allied Market Research projects the global Cannabis market will reach $148.9 billion by 2031, up from $25.7 billion in 2021 – a nearly sixfold increase over a decade, ...
Curaleaf Takes Full Control of Germany’s Four 20 Pharma
STAMFORD – Curaleaf Holdings Inc. closed the final chapter of a four-year German acquisition story, completing the buyout of the remaining 45% stake it did not previously own in Four 20 Pharma GmbH, a move ...
Verano Reports Q1 2026 Financial Results
CHICAGO – Verano Holdings Corp. released its financial results for the three months ended March 31, 2026, showing revenue largely in line with recent quarters as the multi-state Cannabis operator managed wholesale pressures while leaning ...
SNDL Reports Q1 2026 Financial and Operational Results
EDMONTON – SNDL Inc. disclosed a 4.4% drop in net revenue for the three months ended March 31, 2026, as softness in both its Cannabis and liquor businesses weighed on results. The company, which operates ...
Hemp THC Ban Moves Closer as Congressional Fixes Collapse
WASHINGTON – The federal clock on hemp-derived THC products is ticking with no sign of relief from Capitol Hill. Amendments filed last week to delay, or in one case accelerate, the November 12 ban on ...
Helus Pharma Teams Up with TARA Mind on Veteran Mental Health Efforts
NEW YORK – Helus Pharma, a clinical-stage biopharmaceutical company focused on developing novel serotonergic agonists (NSAs) to treat mental health conditions, announced it has joined forces with TARA Mind to help recruit veterans for its ...
Rescheduling: What it Actually Means for US Cannabis
LOS ANGELES – For years, the Cannabis industry's most reliable tradition has been misreading federal signals. When the DEA floated rescheduling proposals, operators popped champagne. When states passed adult-use laws, investors rushed in ahead of ...
DEA Opens Federal Registration Portal for Medical Cannabis Dispensaries
WASHINGTON – The Drug Enforcement Administration (DEA) is set to launch its new online portal on Wednesday, 29 April at 9:00 AM EST, facilitating the application process for state-licensed medical Cannabis dispensaries seeking federal registration ...
Blind Spot: Cannabis Industry Falls Short on Communications
NEW YORK – Legal Cannabis brought in $38.5 billion in revenue in 2024. Whitney Economics estimated that figure to drop to between $29.1 billion and $29.6 billion in 2025, due to falling prices, tax pressures, ...
Cannabis 3.0 — The Body Was Designed to Heal
LOS ANGELES- The cannabis industry is entering a new phase. The first era—Cannabis 1.0—was defined by prohibition and the fight for legalization. Cannabis 2.0 followed, driven by commercialization: brands, retail expansion, and the rapid scaling ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Two weeks that rewrote the rules. That is the most accurate way to characterize what the U.S. Сannabis and Psychedelics industries have experienced heading into the final days of April 2026. Federal ...
IRS and Treasury Move to Clarify Cannabis Tax Rules
WASHINGTON – The U.S. Department of the Treasury and the Internal Revenue Service made an announcement, confirming they will issue formal guidance to address the federal tax consequences of a Department of Justice order that ...
BREAKING: DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential step on Cannabis policy in decades, as Acting Attorney General Todd Blanche formally signed an order moving state-licensed medical Cannabis from Schedule I to Schedule ...
Safe Harbor Targets Retirement Gap in Cannabis Workforce
DENVER – Safe Harbor Financial is extending its reach deeper into workforce benefits, introducing a pooled employer 401(k) plan designed for Cannabis operators that have long struggled to access conventional retirement services. The new offering, ...
AtaiBeckley Reports Expanded Phase 2a Data for EMP-01 in Social Anxiety Disorder
NEW YORK – AtaiBeckley Inc., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, released additional results from its exploratory Phase 2a trial of EMP-01, an oral formulation ...
